Breaking News

China’s CSPC Inks $106M Deal With Allergan Unit

Signs generic oncology pact with Watson Labs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hong Kong-based CSPC Pharmaceutical Group has inked a deal through which its Shijiazhuang-based subsidiary, CSPC Zhongqi Pharmaceutical Technology, entered an agreement with Watson Laboratories, a subsidiary of Allergan. The deal relates to the product technology licensing and commercialization of a complex generic oncology drug in the global market except China. The product is under development by CSPC Zhongqi utilizing its proprietary technology. CSPC Zhongqi is responsible for the pre-clin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters